JP2013536183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536183A5 JP2013536183A5 JP2013523219A JP2013523219A JP2013536183A5 JP 2013536183 A5 JP2013536183 A5 JP 2013536183A5 JP 2013523219 A JP2013523219 A JP 2013523219A JP 2013523219 A JP2013523219 A JP 2013523219A JP 2013536183 A5 JP2013536183 A5 JP 2013536183A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- alkyl
- alkenyl
- wounds
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 33
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 229910052760 oxygen Inorganic materials 0.000 claims 12
- 229910052799 carbon Inorganic materials 0.000 claims 10
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- 206010072170 Skin wound Diseases 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 7
- 230000037303 wrinkles Effects 0.000 claims 6
- 206010052428 Wound Diseases 0.000 claims 5
- 208000027418 Wounds and injury Diseases 0.000 claims 5
- 239000000556 agonist Substances 0.000 claims 5
- 150000001412 amines Chemical class 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 4
- 125000005429 oxyalkyl group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 231100000241 scar Toxicity 0.000 claims 4
- 208000032544 Cicatrix Diseases 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 230000037387 scars Effects 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000000732 arylene group Chemical group 0.000 claims 2
- 210000004709 eyebrow Anatomy 0.000 claims 2
- 150000004820 halides Chemical class 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005549 heteroarylene group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- -1 oxyalkenyl Chemical group 0.000 claims 2
- 230000036573 scar formation Effects 0.000 claims 2
- 208000009043 Chemical Burns Diseases 0.000 claims 1
- 208000034693 Laceration Diseases 0.000 claims 1
- 206010040844 Skin exfoliation Diseases 0.000 claims 1
- 208000002847 Surgical Wound Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 230000000994 depressogenic effect Effects 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 230000002390 hyperplastic effect Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 230000037373 wrinkle formation Effects 0.000 claims 1
- HTNXVEJEYFOLQV-CURYUGHLSA-N C[C@H](c1ccccc1)/N=C(\c1c(C)cc[s]1)/[U]c(cc1)ccc1F Chemical compound C[C@H](c1ccccc1)/N=C(\c1c(C)cc[s]1)/[U]c(cc1)ccc1F HTNXVEJEYFOLQV-CURYUGHLSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36923210P | 2010-07-30 | 2010-07-30 | |
| US61/369,232 | 2010-07-30 | ||
| US41911510P | 2010-12-02 | 2010-12-02 | |
| US61/419,115 | 2010-12-02 | ||
| PCT/US2011/045833 WO2012016109A2 (en) | 2010-07-30 | 2011-07-29 | Compounds and methods for skin repair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013536183A JP2013536183A (ja) | 2013-09-19 |
| JP2013536183A5 true JP2013536183A5 (enExample) | 2014-09-18 |
Family
ID=44543791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013523219A Pending JP2013536183A (ja) | 2010-07-30 | 2011-07-29 | 皮膚修復のための化合物及び方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120136011A1 (enExample) |
| EP (1) | EP2598140B1 (enExample) |
| JP (1) | JP2013536183A (enExample) |
| KR (1) | KR20130130694A (enExample) |
| CN (1) | CN103068382A (enExample) |
| AR (1) | AR082428A1 (enExample) |
| AU (1) | AU2011282549A1 (enExample) |
| BR (1) | BR112013002319A2 (enExample) |
| CA (1) | CA2806982A1 (enExample) |
| CL (1) | CL2013000308A1 (enExample) |
| CO (1) | CO6680670A2 (enExample) |
| MX (1) | MX2013001227A (enExample) |
| NZ (1) | NZ607306A (enExample) |
| PH (1) | PH12013500205A1 (enExample) |
| RU (1) | RU2013108394A (enExample) |
| SG (1) | SG187653A1 (enExample) |
| TW (1) | TW201210601A (enExample) |
| WO (1) | WO2012016109A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697458B2 (en) | 2009-04-22 | 2014-04-15 | Shat-R-Shield, Inc. | Silicone coated light-emitting diode |
| US8889123B2 (en) * | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8697057B2 (en) * | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8883139B2 (en) * | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US8900571B2 (en) * | 2010-08-19 | 2014-12-02 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8741281B2 (en) * | 2010-08-19 | 2014-06-03 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8926963B2 (en) * | 2010-08-19 | 2015-01-06 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| WO2012024072A1 (en) * | 2010-08-19 | 2012-02-23 | Allergan, Inc. | Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition |
| US9005605B2 (en) * | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8894992B2 (en) * | 2010-08-19 | 2014-11-25 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US20120142684A1 (en) * | 2010-12-02 | 2012-06-07 | Allergan, Inc. | Compounds and methods for skin repair |
| JP2015537028A (ja) * | 2012-11-16 | 2015-12-24 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 皮膚修復のための組成物および方法 |
| CA2890034A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations |
| ES2730895T3 (es) * | 2013-09-27 | 2019-11-13 | Allergan Inc | Compuestos y métodos para reparación cutánea |
| RU2625548C1 (ru) * | 2015-04-29 | 2017-07-14 | Жанна Юрьевна Юсова | Способ коррекции возрастных изменений кожи лица |
| RU2663391C1 (ru) * | 2018-01-30 | 2018-08-03 | Игорь Николаевич Бондаренко | Способ эстетической коррекции мягких тканей лица |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| TWI249520B (en) * | 1998-07-15 | 2006-02-21 | Ono Pharmaceutical Co | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient |
| WO2000015608A1 (fr) * | 1998-09-14 | 2000-03-23 | Ono Pharmaceutical Co., Ltd. | Derives e de phenyl-prostaglandine a substitution-φ et medicaments les contenant comme ingredient actif |
| JP4618548B2 (ja) * | 1999-11-24 | 2011-01-26 | 小野薬品工業株式会社 | 骨量低下疾患治療剤 |
| KR100826866B1 (ko) * | 2001-07-23 | 2008-05-06 | 오노 야꾸힝 고교 가부시키가이샤 | Ｅｐ４ 아고니스트를 유효 성분으로 하는 골량 저하질환의 치료제 |
| US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| WO2004032965A1 (ja) * | 2002-10-10 | 2004-04-22 | Ono Pharmaceutical Co., Ltd. | 内因性修復因子産生促進剤 |
| US6875787B2 (en) | 2003-02-11 | 2005-04-05 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| AU2004211936B2 (en) * | 2003-02-11 | 2008-09-11 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| US7855226B2 (en) * | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| JPWO2006016695A1 (ja) * | 2004-08-10 | 2008-05-01 | 小野薬品工業株式会社 | Ｅｐ４アゴニストを含有してなる高カリウム血症の予防および／または治療剤 |
| JP2006321737A (ja) * | 2005-05-18 | 2006-11-30 | Ono Pharmaceut Co Ltd | Ｅｐ４アゴニストを含有する神経変性疾患の予防、治療および／または進展抑制剤 |
| JP2007023028A (ja) * | 2005-06-16 | 2007-02-01 | Ono Pharmaceut Co Ltd | 内耳疾患治療剤 |
| US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
| US7439372B2 (en) * | 2006-05-03 | 2008-10-21 | Allergan, Inc. | Therapeutic compounds |
| BRPI0720254A2 (pt) * | 2006-12-15 | 2014-01-07 | Glaxo Group Ltd | Derivados de benzamida como agonistas do receptor ep4 |
| US20100081631A1 (en) * | 2006-12-18 | 2010-04-01 | Guang Liang Jiang | Methods and compositions for treating gastrointenstial disorders |
| US8507545B2 (en) * | 2007-05-08 | 2013-08-13 | National University Corporation, Hamamatsu University School Of Medicine | Cytotoxic T cell activator comprising EP4 agonist |
| GB0810615D0 (en) * | 2008-06-10 | 2008-07-16 | Glaxo Group Ltd | Novel pharmaceutical |
-
2011
- 2011-07-29 MX MX2013001227A patent/MX2013001227A/es not_active Application Discontinuation
- 2011-07-29 CN CN2011800404387A patent/CN103068382A/zh active Pending
- 2011-07-29 PH PH1/2013/500205A patent/PH12013500205A1/en unknown
- 2011-07-29 KR KR1020137004837A patent/KR20130130694A/ko not_active Withdrawn
- 2011-07-29 WO PCT/US2011/045833 patent/WO2012016109A2/en not_active Ceased
- 2011-07-29 AR ARP110102761A patent/AR082428A1/es unknown
- 2011-07-29 CA CA2806982A patent/CA2806982A1/en not_active Abandoned
- 2011-07-29 BR BR112013002319A patent/BR112013002319A2/pt not_active IP Right Cessation
- 2011-07-29 SG SG2013007430A patent/SG187653A1/en unknown
- 2011-07-29 EP EP11744157.6A patent/EP2598140B1/en not_active Not-in-force
- 2011-07-29 RU RU2013108394/15A patent/RU2013108394A/ru not_active Application Discontinuation
- 2011-07-29 TW TW100127126A patent/TW201210601A/zh unknown
- 2011-07-29 NZ NZ60730611A patent/NZ607306A/en not_active IP Right Cessation
- 2011-07-29 US US13/194,078 patent/US20120136011A1/en not_active Abandoned
- 2011-07-29 AU AU2011282549A patent/AU2011282549A1/en not_active Abandoned
- 2011-07-29 JP JP2013523219A patent/JP2013536183A/ja active Pending
-
2013
- 2013-01-30 CL CL2013000308A patent/CL2013000308A1/es unknown
- 2013-02-26 CO CO13038986A patent/CO6680670A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013536183A5 (enExample) | ||
| JP2013544842A5 (enExample) | ||
| RU2013108394A (ru) | Соединения и способы восстановления кожи | |
| RU2013129262A (ru) | Соединения и способы для восстановления кожи | |
| BR112017020132A2 (pt) | métodos para promover o crescimento capilar ou prevenir a perda de cabelo em um indivíduo e para preparar uma composição, e, composição | |
| RU2014113663A (ru) | Композиции кожного наполнителя для лечения мелких морщин | |
| EA201792559A1 (ru) | Фармацевтические композиции для местного применения | |
| JP2017214429A5 (enExample) | ||
| JP2016525102A5 (enExample) | ||
| JP2014511891A5 (enExample) | ||
| PH12016501357A1 (en) | Pharmaceutical preparation containing pyridylamino acetic acid compound | |
| JP2019510034A5 (enExample) | ||
| BR112015019039A8 (pt) | compostos antagonistas de integrina fluorados, composição farmacêutica compreendendo ditos compostos e uso destes para tratar ou prevenir uma doença ou condição mediada por uma av integrina | |
| CN113825754A (zh) | 包括甲基和三氟甲基的双取代磺酰胺类选择性bcl-2抑制剂 | |
| JP2019501879A5 (enExample) | ||
| JP2016510048A (ja) | 毛髪処理の方法 | |
| CN1679480A (zh) | 毛发化妆品 | |
| JP2015517567A (ja) | デヒドロアビエチン酸を有効成分として含有する抗老化用組成物 | |
| JP2016514150A5 (enExample) | ||
| CN1679476A (zh) | 毛发化妆品 | |
| RU2014128387A (ru) | Ингибиторы рi3к для лечения фиброзных заболеваний | |
| JP2015537028A5 (enExample) | ||
| JP2015537028A (ja) | 皮膚修復のための組成物および方法 | |
| CN108135815A (zh) | 含有细胞老化抑制剂作为有效成分的皮肤皱纹改善用及皮肤损伤炎症疾病治疗用组合物 | |
| RU2019136694A (ru) | Фенил-2-гидрокси-ацетиламино-2-метил-фениловые соединения |